Home » Topics » Regulatory

Regulatory
RSS

FDA approval for Invanz

Dec. 22, 2006

Pediatric indication approved for Colazal

Dec. 22, 2006

FDA approval for Bio-E-Gel, to be marketed as Elestrin

Dec. 19, 2006

MuGard receives FDA approval

Dec. 14, 2006

Abilify Injection now available

Dec. 14, 2006

Velcade approved for relapsed mantle cell lymphoma

Dec. 12, 2006

Humira receives approval for expanded indication in psoriatic arthritis

Nov. 15, 2006

FDA approval for Polyphenon E Ointment

Nov. 2, 2006

Japanese approval for Sonazoid ultrasound contrast medium

Oct. 27, 2006

Noxafil approved for treatment of oropharyngeal candidiasis

Oct. 25, 2006

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 16, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 16, 2025.
CTAD 2025: Diagnosing semaglutide’s failure in Alzheimer’s trials
BioWorld
A little over a week after announcing that the Evoke and Evoke+ studies failed to show that oral semaglutide could slow cognition decline in patients with...
Hits’ Hyperlab launches as ‘virtual AI lab’ for new drug discovery
BioWorld Science
Things once done in laboratories can now be done with computers and AI, said Kim Woo-youn, CEO and cofounder of Hits Inc. “We live in the age of ‘digital...
ADEL wins $1.04B Sanofi deal for tau-targeting Alzheimer’s drug
BioWorld
ADEL Inc. closed a year-end licensing deal worth up to $1.04 billion with Sanofi SA for ADEL-Y01, a specific tau-targeting Alzheimer’s disease drug candidate in a...